In tumors characterized by a high osteotropism, such as multiple myeloma, the measurement of bone metabolism markers is helpful in monitoring both severity and prognosis of the skeletal disease. Here, we review the pathophysiology of these markers including tartrate resistant acid phosphatase (TRAcP), which appears highly specific and closely related to the extent of myeloma bone lesions.
|Translated title of the contribution||Novel markers in osteo-oncology: The tartrate resistant acid phosphatase in myeloma bone disease|
|Number of pages||8|
|Journal||Recenti Progressi in Medicina|
|Publication status||Published - Feb 2011|
ASJC Scopus subject areas